Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.11.2016 | Case report

Dasabuvir/ombitasvir/paritaprevir/ritonavir

Skin lesions, mood changes, aggressiveness and suicidal ideation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat De Miguel Bouzas JC, et al. Suicidal ideation in patients treated with ombitasvir/paritaprevir/ ritonavir (Viekirax), dasabuvir (Exviera) and ribavirina (Rebetol). Farmacia Hospitalaria 40: 451-452, No. 5, 2016. Available from: URL: http://doi.org/10.7399/fh.2016.40.5.10553 [Spanish; summarised from a translation] - SpainPubMed De Miguel Bouzas JC, et al. Suicidal ideation in patients treated with ombitasvir/paritaprevir/ ritonavir (Viekirax), dasabuvir (Exviera) and ribavirina (Rebetol). Farmacia Hospitalaria 40: 451-452, No. 5, 2016. Available from: URL: http://​doi.​org/​10.​7399/​fh.​2016.​40.​5.​10553 [Spanish; summarised from a translation] - SpainPubMed
Metadaten
Titel
Dasabuvir/ombitasvir/paritaprevir/ritonavir
Skin lesions, mood changes, aggressiveness and suicidal ideation: case report
Publikationsdatum
01.11.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-22645-z

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Minocycline

Case report

Adalimumab

Case report

Ponatinib

Case report

Bupivacaine

Case report

Iguratimod